Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1566247 | 0.98 | ALDH1A1 (0.62) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| Hydrochloric Acid SCHEMBL117725 | 0.98 | ALDH1A1 (0.62) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| Phosphonic Acid SCHEMBL27912432 | 0.91 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDHTTL3MBTL1 | |
| Formic Acid SCHEMBL28091396 | 0.91 | ALDH1A1 (0.55) | ALDH1A1TSHRHPGDHTTL3MBTL1 | |
| SCHEMBL30408060 | 0.85 | ALDH1A1 (0.62) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL1811434 | 0.85 | ALDH1A1 (0.62) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL3202573 | 0.84 | ALDH1A1 (0.72) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| Hydrochloric Acid SCHEMBL3652038 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| Hydrochloric Acid SCHEMBL31250676 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRHPGDHTTHSD17B10 | |
| SCHEMBL301933 | 0.82 | ALDH1A1 (0.69) | ALDH1A1TSHRHPGDHTTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 608 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119977906-A | A-site cation-regulated halide perovskite, and preparation method and application thereof | 西北大学 | 2025-05-13 | — | — | CN | claimed |
| US-12247089-B2 | Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit | Zhongshan Guanghe Medical Technology Co., Ltd. (CN) | 2025-03-11 | — | — | US | claimed |
| CN-117801754-A | Water-based adhesive, preparation method thereof and electrode plate | 广州鹿山新材料股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-113912867-B | Preparation method of polyglutamate hydrogel and product | 西安德诺海思医疗科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| WO-2023019148-A1 | MACROMOLECULE ENRICHMENT | PrognomIQ, Inc. (US) | 2023-02-16 | — | — | WO | claimed |
| WO-2023009099-A1 | PCR KIT-OF-PARTS, METHOD AND SYSTEM | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2023-02-02 | — | — | WO | claimed |
| US-20220289684-A1 | BENZIMIDAZOLE SUBSTITUTION-BASED PHENYL N-BUTYRAMIDE COMPOUND AND PREPARATION METHOD THEREFOR | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2022-09-15 | — | — | US | claimed |
| CN-113912867-A | Preparation method and product of polyglutamate hydrogel | 西安德诺海思医疗科技有限公司 | 2022-01-11 | — | — | CN | claimed |
| US-11117879-B2 | Photo-crosslinked hydrogel material and preparation, composition, and application thereof photo-crosslinked hydrogel | Zhongshan Guanghe Medical Technology Co., Ltd. (CN) | 2021-09-14 | — | — | US | claimed |
| CN-112441984-A | Benzimidazole substituted phenyl n-butylamide-based compound and preparation method thereof | 上海特化医药科技有限公司 | 2021-03-05 | — | — | CN | claimed |
| EP-0881229-B1 | Alkylated antibiotic hexapeptides | LILLY CO ELI (US) | 2003-07-09 | — | — | EP | claimed |
| EP-0892813-A4 | RECOMBINANT PREPARATION OF CALCITONIN FRAGMENTS AND USE THEREOF IN THE PREPARATION OF CALCITONIN AND RELATED ANALOGS | BIONEBRASKA INC (US) | 2003-02-05 | — | — | EP | claimed |
| US-20010031856-A1 | Forming fusion protein which includes target sequence linked to carbonic anhydrase through cleavage site and cleaving fusion protein with cleavage reagent to produce first polypeptide including target sequence | BIO NEBRASKA, INC. | 2001-10-18 | — | — | US | claimed |
| US-6251635-B1 | CONDENSING AN N-TERMINAL FRAGMENT OF DEFINED AMINO ACID SEQUENCE WITH RECOMBINANTLY-FORMED POLYPEPTIDE OF DEFINED AMINO ACID SEQUENCE IN PRESENCE OF NON-ENZYMATIC COUPLING REAGENT | BIONEBRASKA, INC. | 2001-06-26 | — | — | US | claimed |
| US-6180631-B1 | PREVENTING AND TREATING SERINE/THREONINE PROTEIN KINASE-RELATED ABNORMAL CONDITIONS IN MAMMALS ASSOCIATED WITH AN ABERRATION IN A SIGNAL TRANSDUCTION PATHWAY SUCH AS CANCER OR A FIBROTIC DISORDER | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 2001-01-30 | — | — | US | claimed |
| US-5962270-A | TRANSFORMING HOST CELL WITH VECTOR ENCODING A FUSION PROTEIN OF CARBONIC ANHYDRASE, LINKER PEPTIDE, AND CALCITONIN; CULTURING CELL TO EXPRESS FUSION PROTEIN, CLEAVING PROTEIN WITH HYDROXYLAMINE AT LINKER PEPTIDE | BIONEBRASKA, INC. (US) | 1999-10-05 | — | — | US | claimed |
| EP-0892813-A1 | RECOMBINANT PREPARATION OF CALCITONIN FRAGMENTS AND USE THEREOF IN THE PREPARATION OF CALCITONIN AND RELATED ANALOGS | BIONEBRASKA, INC. (US) | 1999-01-27 | — | — | EP | claimed |
| WO-1997029127-A1 | RECOMBINANT PREPARATION OF CALCITONIN FRAGMENTS AND USE THEREOF IN THE PREPARATION OF CALCITONIN AND RELATED ANALOGS | BIONEBRASKA, INC. (US) | 1997-08-14 | — | — | WO | claimed |
| WO-1996017941-A2 | PRODUCTION OF C-TERMINAL AMIDATED PEPTIDES FROM RECOMBINANT PROTEIN CONSTRUCTS | BIONEBRASKA, INC. (US) | 1996-06-13 | — | — | WO | claimed |
| US-4958018-A | REACTING A 3-HALOMETHYL-3-CEPHEM WITH A LEAD REDUCING AGENT | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1990-09-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12247089-B2 | Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit | PKN3, JAK3, KIT | ALDH1A1 92/4885TSHR 3722/4885HPGD 227/4885 |
| US-11117879-B2 | Photo-crosslinked hydrogel material and preparation, composition, and application thereof photo-crosslinked hydrogel | JAK3, ILK, JAK1 | ALDH1A1 964/4885TSHR 2209/4885HPGD 3483/4885 |
| US-20010031856-A1 | Forming fusion protein which includes target sequence linked to carbonic anhydrase through cleavage site and cleaving fusion protein with cleavage reagent to produce first polypeptide including target sequence | CA1, CA11, CA14 | ALDH1A1 4401/4885TSHR 1928/4885HPGD 1988/4885 |
| US-20220289684-A1 | BENZIMIDAZOLE SUBSTITUTION-BASED PHENYL N-BUTYRAMIDE COMPOUND AND PREPARATION METHOD THEREFOR | PAH, PNP, CYP3A4 | ALDH1A1 1641/4885TSHR 4202/4885HPGD 1449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.